Increased tumour growth inhibition has been reported when this has been combined with carboplatin or radiotherapy in vivo, and single-agent anti-tumour activity has been seen in ATM-deficient but not ATM-proficient xenograft models [93]. Here, ATM is linked to neoplasm.